GGrantIndex
Sort

172,184 grants matching inflammation

Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic disease (PACI) Initiative

$2,242,308
Nehal Mehta · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease

$2,241,456
Lisa L Barnes · Rush University Medical Center · R01 · FY2025 · AG

Integrative Neurobiology of Cardiovascular Regulation

$2,240,802
Francois M Abboud · University Of Iowa · P01 · FY2015 · HL

Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer

$2,239,851
Steven M. Dubinett · University Of California Los Angeles · U01 · FY2016 · CA

Center for Addiction and Disease Risk Exacerbation

$2,239,343
Peter M. Monti · Brown University · P20 · FY2021 · GM

The Role of Airborne PAHs and DEP in the Pathogenesis of Childhood Asthma

$2,238,305
Frederica P Perera · Columbia University Health Sciences · P50 · FY2007 · ES

Chemical Mediators of Acute Pulmonary Disorders

$2,237,772
Brigham And Women'S Hospital · P01 · FY2005 · HL

Molecular Mechanisms Regulating Calcium Flux In Salivary Glands

$2,237,203
Indu S. Ambudkar · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE

Cell surface proteolysis in development, tissue repair, and malignancy

$2,236,886
Thomas H Bugge · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE

Immunomodulatory and regenerative effects of mesenchymal stem cells on allografts

$2,236,659
Norma Sue Kenyon · University Of Miami School Of Medicine · P01 · FY2014 · AI

Regulation of pulmonary inflammation by leukocytes and extracellular matrix

$2,236,282
Steven F Ziegler · Benaroya Research Inst At Virginia Mason · P01 · FY2014 · HL

Center for Leadership in Environmental Awareness and Research

$2,236,247
Melissa A Runge-Morris · Wayne State University · P42 · FY2023 · ES

Early Life Stress Induced Mechanisms of Cardiovascular Disease Risk and Resilience

$2,236,225
Jennifer S Pollock · University Of Alabama At Birmingham · P01 · FY2025 · HL

Glycobiology of Inflammatory Lung Diseases

$2,236,155
Ronald L Schnaar · Johns Hopkins University · P01 · FY2017 · HL

Long-term Follow-up of the Systemic Immunosuppressive Therapy for Eye Diseases Cohort

$2,236,075
John H. Kempen · Massachusetts Eye And Ear Infirmary · R01 · FY2025 · EY

Center for Lung Biology and Disease

$2,235,991
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2023 · GM

Clinical Genomics and Experimental Therapeutics

$2,235,970
Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA

Project 2: Aging Healthy Together: Precision Profiles of Resilience and Risk

$2,235,915
Lee Ryan · University Of Arizona · U19 · FY2023 · AG

Activities Of Chemokines In Health and Disease

$2,234,688
Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)

$2,234,624
Eti Yoles · Immunobrain Checkpoint Inc. · R01 · FY2022 · AG

ENDOTHELIN CONTROL OF RENAL HEMODYNAMIC AND EXCRETORY FUNCTION

$2,234,430
David M Pollock · Augusta University · P01 · FY2011 · HL

Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)

$2,233,701
Tracy E Crane · University Of Miami School Of Medicine · R01 · FY2025 · CA

Center for Addiction and Disease Risk Exacerbation

$2,232,943
Peter M. Monti · Brown University · P20 · FY2023 · GM

High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC

$2,231,942
Yvonne W Wu · University Of California, San Francisco · U01 · FY2016 · NS

The Function and Mechanisms of Autophagy in Spinal Cord Injury

$2,231,793
Junfang Wu · University Of Maryland Baltimore · RF1 · FY2022 · NS